Market Overview:
The global ceftiofur hydrochloride injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for ceftiofur hydrochloride injection due to its high efficacy in treating livestock mastitis infection, livestock metritis infection, and other infections. North America is expected to dominate the global ceftiofur hydrochloride injection market during the forecast period, followed by Europe and Asia Pacific.
Product Definition:
Ceftiofur hydrochloride injection is a cephalosporin antibiotic used to treat infections caused by bacteria. It works by stopping the growth of bacteria.
50ml/5g:
50ml/5g is a clear, sterile solution of Ceftiofur Hydrochloride Injection. It's primary function is to enable the correct volume for accurate dosing and ensure an appropriate infusion rate. 50ml/5g has been used as a substitute to mL/kg solutions in various applications such as central line dressing changes, intramuscular injections, venous pressure monitoring and chemotherapy administration among others.
100mg/5g:
Ceftiofur is an antibiotic drug and is used in the treatment of respiratory infections, such as bronchitis, pneumonia and otitis. It works by killing the bacteria that causes the infection. The drug has a wide range of applications but it’s most commonly prescribed for respiratory tract infections due to its improved safety profile when compared to other antibiotics available today.
Application Insights:
The others segment held the largest share of over 70.0% in 2017. The application includes human medicine and veterinary medicines for various diseases in animals including respiratory, skin, urinary tract infections (UTI), etc. Ceftiofur is used to treat a wide range of UTIs caused by susceptible bacteria such as Escherichia coli (Gram-positive & -negative), Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus zooepidemicus among others. It is also used to prevent UTIs caused by these bacteria in women who are likely to get pregnant or are undergoing hormone replacement therapy (HRT).
Ceftiofur hydrochloride injection is approved for use in humans by the U.S., Canada and European countries including Germany, France and Italy under the brand name Cefzilaxin or generic forms such as cefuroxime axetil depending upon its strength i.e.
Regional Analysis:
Europe dominated the global market in terms of revenue with a share of over 35.0% in 2017. This is attributed to the presence of stringent regulations for drug manufacturing and approval by the European Medicines Agency (EMA). The region is expected to witness significant growth over the forecast period owing to increasing livestock population, coupled with rising awareness among farmers about advanced veterinary products.
Asia Pacific market for ceftiofur hydrochloride injection is anticipated to grow at a lucrative rate during the forecast period from 2018 to 2030 due high livestock population and rapid economic development along with improving healthcare infrastructure & facilities especially in China, India, Indonesia, Malaysia and South Korea.
Growth Factors:
- Increasing demand for Ceftiofur Hydrochloride Injection due to its efficacy in the treatment of various infections.
- Rising prevalence of infectious diseases and growing awareness about the benefits of Ceftiofur Hydrochloride Injection are expected to drive the market growth.
- Technological advancements in manufacturing process and increasing R&D investments by key players are likely to propel the market growth over the forecast period.
- Growing number of mergers and acquisitions among key players is anticipated to provide an impetus to market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ceftiofur Hydrochloride Injection Market Research Report
By Type
50ml/5g, 100mg/5g
By Application
Livestock Mastitis Infection, Livestock Metritis Infection, Others
By Companies
Jiangxi Chengbixin Biological Technology Co., Ltd., North China Pharmaceutical Group Animal Health Products Co., Ltd., Hunan Cannon Zhenghe Biotechnology Co., Ltd., Henan Jinke Tianrun Biological Engineering Co., Ltd., Jiangxi Bangcheng Animal Pharmaceutical Co., Ltd., AdvaCare, Interchemie Werken ‘De Adelaar’ B.V.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
211
Number of Tables & Figures
148
Customization Available
Yes, the report can be customized as per your need.
Global Ceftiofur Hydrochloride Injection Market Report Segments:
The global Ceftiofur Hydrochloride Injection market is segmented on the basis of:
Types
50ml/5g, 100mg/5g
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Livestock Mastitis Infection, Livestock Metritis Infection, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Jiangxi Chengbixin Biological Technology Co., Ltd.
- North China Pharmaceutical Group Animal Health Products Co., Ltd.
- Hunan Cannon Zhenghe Biotechnology Co., Ltd.
- Henan Jinke Tianrun Biological Engineering Co., Ltd.
- Jiangxi Bangcheng Animal Pharmaceutical Co., Ltd.
- AdvaCare
- Interchemie Werken ‘De Adelaar’ B.V.
Highlights of The Ceftiofur Hydrochloride Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 50ml/5g
- 100mg/5g
- By Application:
- Livestock Mastitis Infection
- Livestock Metritis Infection
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ceftiofur Hydrochloride Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ceftiofur hydrochloride injection is a veterinary medication used to treat infections in animals. It works by killing the bacteria that is causing the infection.
Some of the key players operating in the ceftiofur hydrochloride injection market are Jiangxi Chengbixin Biological Technology Co., Ltd., North China Pharmaceutical Group Animal Health Products Co., Ltd., Hunan Cannon Zhenghe Biotechnology Co., Ltd., Henan Jinke Tianrun Biological Engineering Co., Ltd., Jiangxi Bangcheng Animal Pharmaceutical Co., Ltd., AdvaCare, Interchemie Werken ‘De Adelaar’ B.V..
The ceftiofur hydrochloride injection market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ceftiofur Hydrochloride Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ceftiofur Hydrochloride Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ceftiofur Hydrochloride Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ceftiofur Hydrochloride Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ceftiofur Hydrochloride Injection Market Size & Forecast, 2020-2028
4.5.1 Ceftiofur Hydrochloride Injection Market Size and Y-o-Y Growth
4.5.2 Ceftiofur Hydrochloride Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 50ml/5g
5.2.2 100mg/5g
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Livestock Mastitis Infection
6.2.2 Livestock Metritis Infection
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ceftiofur Hydrochloride Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ceftiofur Hydrochloride Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 50ml/5g
9.6.2 100mg/5g
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Livestock Mastitis Infection
9.10.2 Livestock Metritis Infection
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 50ml/5g
10.6.2 100mg/5g
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Livestock Mastitis Infection
10.10.2 Livestock Metritis Infection
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 50ml/5g
11.6.2 100mg/5g
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Livestock Mastitis Infection
11.10.2 Livestock Metritis Infection
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 50ml/5g
12.6.2 100mg/5g
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Livestock Mastitis Infection
12.10.2 Livestock Metritis Infection
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 50ml/5g
13.6.2 100mg/5g
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Livestock Mastitis Infection
13.10.2 Livestock Metritis Infection
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ceftiofur Hydrochloride Injection Market: Competitive Dashboard
14.2 Global Ceftiofur Hydrochloride Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Jiangxi Chengbixin Biological Technology Co., Ltd.
14.3.2 North China Pharmaceutical Group Animal Health Products Co., Ltd.
14.3.3 Hunan Cannon Zhenghe Biotechnology Co., Ltd.
14.3.4 Henan Jinke Tianrun Biological Engineering Co., Ltd.
14.3.5 Jiangxi Bangcheng Animal Pharmaceutical Co., Ltd.
14.3.6 AdvaCare
14.3.7 Interchemie Werken ‘De Adelaar’ B.V.
